EDITOR'S PICKS
DEEP DIVES
PE seeks pharmaceutical and life sciences consulting firms: 7 deals
Blackstone, Audax, Bridgepoint and Baird are among the PE firms targeting add-ons for pharmaceutical and life science consultancy platforms.
TECH WATCH
HEALTHCARE
THOUGHT LEADERSHIP
SPECIAL REPORTS
INDUSTRIAL/MANUFACTURING
ENERGY/POWER
VOX POPULI
Healthcare M&A in 2026: Five rules smart sponsors are following
Dealmaking is on the upswing, but sponsors need to rethink their methods to get to the finish line, writes Matthew Brohm of Arnall Golden Gregory.
Why pharmacy remains a compelling mid-market play
Stability continues to present pharmacy as a compelling, high-resilience investment opportunity, write Mike Hess and Dawn Perez-Slavinski of Bass, Berry & Sims.
Private wealth changes the game and breaks operating models
Many firms are scaling their private wealth efforts without a clear understanding of where capital is truly coming from, writes Liz Gaffney of InvestorFlow.
